ロード中...
Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
At the time of writing this commentary (February 2020), the coronavirus COVID‐19 epidemic has already resulted in more fatalities compared with the SARS and MERS coronavirus epidemics combined. Therapeutics that may assist to contain its rapid spread and reduce its high mortality rates are urgently...
保存先:
| 出版年: | Drug Dev Res |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228359/ https://ncbi.nlm.nih.gov/pubmed/32129518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21656 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|